Government opts for additional consultation on National Medicines Policy review

24 March 2022 - The Government has heeded the calls from Medicines Australia, patient groups, health bodies, and industry by ...

Read more →

National Medicines Policy too important to be rushed before Federal Election

10 February 2022 - Following consultation with members – and heeding the concerns of the Consumers Health Forum and patient ...

Read more →

Review of the National Medicines Policy – consultation on draft National Medicines Policy extended

8 February 2022 - The consultation period on the draft NMP was due to close on Wednesday 16 February 2022.  ...

Read more →

Medicines Australia calls for new National Medicines Policy to be pushed back until after the federal election

4 February 2022 - Medicines Australia is today calling for the new National Medicines Policy to be pushed back until ...

Read more →

Review of the National Medicines Policy – consultation on the draft closes 16 February 2022

2 February 2022 - Since August 2021, the Committee has heard from nearly 200 stakeholders through bilateral interviews and virtual group ...

Read more →

How are child specific utility instruments used in decision making in Australia? A review of Pharmaceutical Benefits Advisory Committee public summary documents.

28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...

Read more →

National Medicines Policy Review – publication of submissions

21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...

Read more →

Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology

25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...

Read more →

Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies

25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...

Read more →

Review of the National Medicines Policy

11 October 2021 - The call for submissions closed on Friday 8 October 2021 and a total of 107 submissions have ...

Read more →

Review of the National Medicines Policy – call for submissions

30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...

Read more →

National Medicines Policy Review Committee and Terms of Reference

3 August 2021 - The National Medicines Policy has influenced a number of important strategies, frameworks and programs developed since ...

Read more →

National Medicines Policy Review will be significant for all Australians

30 July 2021 - Medicines Australia is eager to be part of a significant moment in history for Australian health ...

Read more →

Announcement of the National Medicines Policy Review Committee and Terms of Reference

30 August 2021 -  The Minister for Health has established an Expert Advisory Committee to lead the Review of the National ...

Read more →

National Medicines Policy review to begin in August 2021

24 June 2021 - The review of the National Medicines Policy will begin in August 2021. ...

Read more →